Table 1.
Physician Specialty | Cancer Type (%) |
|||||||
---|---|---|---|---|---|---|---|---|
All (n = 2,470) | Lung/Larynx (n = 238) | Female Breast (n = 558) | Prostate (n = 421) | Colorectal (n = 276) | Lymphoma/Leukemia (n = 317) | Melanoma (n = 61) | Other Cancers (n = 599) | |
Oncology | 41.9 | 35.3 | 60.1 | 13.7 | 54.5 | 55.9 | 28.6* | 39.3 |
Urology | 15.0 | 0.0 | 0.0 | 69.7 | 0.0 | 0.0 | 0.0 | 13.9 |
Hematology | 7.2* | 9.2* | 10.0* | 2.2* | 5.4* | 15.5* | 0.0 | 5.4* |
Dermatology | 3.8 | 0.0 | 0.0 | 0.0 | 1.2* | 1.0* | 64.7 | 4.8* |
General surgery | 10.8 | 2.7* | 17.4 | 0.0 | 26.7* | 8.6* | 6.7* | 11.6* |
Primary care | 9.8 | 10.7* | 12.1* | 9.0 | 8.8* | 10.0* | 0.0 | 9.7 |
Other | 11.4 | 42.0 | 0.4* | 5.4* | 3.3* | 8.9* | 0.0 | 15.2 |
NOTE. Visits were considered cancer related if the principal diagnosis was coded as a malignant neoplasm (ICD-9-CM, 140-208). Nonmelanoma skin cancer is excluded. Oncology specialty includes gynecologic oncology, hematology/oncology, musculoskeletal oncology, medical oncology, pediatric hematology/oncology, surgical oncology.
Abbreviation: ICD-9-CM, International Classification of Diseases, ninth revision, clinical modification.
Estimates based on fewer than 30 observations and/or with a relative SE > 0.30 are considered unreliable by the standards of the National Center for Health Statistics.